MedPath
Found 27 clinical trials|View Analysis
Sort by:

Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis

Phase 3
Recruiting
Conditions
Stroke, Ischemic
Atherosclerosis
Myocardial Infarction
Cerebral Infarction
Stroke
Coronary Syndrome
TIA
Cardiac Disease
Interventions
First Posted Date
2022-07-27
Last Posted Date
2024-06-03
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
2800
Registration Number
NCT05476991
Locations
🇫🇷

URC Lariboisière-Fernand Widal-Saint Louis, Paris, France

Testing P2Y12 Platelet Inhibitors Generics Beyond Bioequivalence

Phase 3
Completed
Conditions
Cardiovascular Diseases
Acute Coronary Syndrome
Interventions
First Posted Date
2022-07-26
Last Posted Date
2022-07-26
Lead Sponsor
Cairo University
Target Recruit Count
29
Registration Number
NCT05474053
Locations
🇪🇬

Faculty of Medicine, Cairo, Egypt

Ticagrelor Monotherapy After Stenting

Phase 2
Recruiting
Conditions
Acute Myocardial Infarction
Interventions
First Posted Date
2021-12-08
Last Posted Date
2024-05-16
Lead Sponsor
Vastra Gotaland Region
Target Recruit Count
200
Registration Number
NCT05149560
Locations
🇸🇪

Kardiologen, Gothenburg, Sweden

Replication of the ISAR-REACT 5 Antiplatelet Trial in Healthcare Claims Data

Completed
Conditions
Acute Coronary Syndrome
Interventions
First Posted Date
2021-10-20
Last Posted Date
2023-07-27
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
28389
Registration Number
NCT05086081
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

1-month DAPT Plus 5-month Ticagrelor Monotherapy Versus 12-month DAPT in Patients With Drug-coated Balloon

First Posted Date
2021-07-21
Last Posted Date
2023-11-14
Lead Sponsor
Xijing Hospital
Target Recruit Count
1948
Registration Number
NCT04971356
Locations
🇨🇳

Ling Tao, Xi'an, Shannxi, China

Bioequivalence Study of Anplag® 90mg (Ticagrelor) Tablet & Brilinta® 90 mg (Ticagrelor) Tablet in Healthy Adult Male Pakistani Subjects Under Fasting Condition

Phase 1
Completed
Conditions
Healthy Individuals
Interventions
First Posted Date
2021-06-28
Last Posted Date
2022-09-08
Lead Sponsor
University of Karachi
Target Recruit Count
30
Registration Number
NCT04941196
Locations
🇵🇰

Center for Bioequivalence Studies and clinical research, Karachi, Sindh, Pakistan

Optical Coherence Tomography-Guided PCI With Single-Antiplatelet Therapy

Phase 2
Completed
Conditions
Non ST Segment Elevation Acute Coronary Syndrome
Interventions
First Posted Date
2021-02-23
Last Posted Date
2023-03-06
Lead Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Target Recruit Count
75
Registration Number
NCT04766437
Locations
🇳🇱

Amsterdam UMC, location AMC, Amsterdam, Netherlands

Ticagrelor De-escalation Strategy in East Asian Patients With AMI

Phase 4
Conditions
Acute Myocardial Infarction
Interventions
First Posted Date
2021-02-16
Last Posted Date
2021-02-16
Lead Sponsor
Dong-A University
Target Recruit Count
2000
Registration Number
NCT04755387
Locations
🇰🇷

DongA University Hospital, Busan, Korea, Republic of

Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACS

Phase 3
Completed
Conditions
Acute Coronary Syndrome
STEMI
NSTEMI
Coronary Artery Disease
Myocardial Infarction
Interventions
First Posted Date
2021-02-04
Last Posted Date
2022-07-07
Lead Sponsor
Federico II University
Target Recruit Count
50
Registration Number
NCT04739384
Locations
🇮🇹

Professor Giovanni Esposito, Naples, Italy

Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke

Phase 3
Completed
Conditions
Ischemic Stroke
Transient Ischemic Attack
Interventions
First Posted Date
2021-02-04
Last Posted Date
2023-10-19
Lead Sponsor
Mazandaran University of Medical Sciences
Target Recruit Count
90
Registration Number
NCT04738097
Locations
🇮🇷

Athena Sharifi Razavi, Sari, Mazandaran, Iran, Islamic Republic of

🇮🇷

Bou-Ali Sina hospital , Mazandarn University of Medical Science, Sari, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath